Parker Geoffrey M. 4
4 · Allogene Therapeutics, Inc. · Filed Jan 28, 2025
Insider Transaction Report
Form 4
Parker Geoffrey M.
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2025-01-24+173,913→ 1,305,901 total - Award
Stock Option (Right to buy)
2025-01-24+614,844→ 614,844 totalExercise: $1.94Exp: 2035-01-24→ Common Stock (614,844 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.